{"url_path":"/sec/abbv/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","accession_number":"0001551152-26-000017","cik":"0001551152","ticker":"ABBV","issuer_name":"AbbVie Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1551152/0001551152-26-000017-index.html","primary_entity_key":"0001551152","primary_entity_name":"AbbVie Inc."},"word_count":26,"has_tables":true,"body_markdown":"ITEM 1. LEGAL PROCEEDINGS\n\nInformation pertaining to legal proceedings is provided in Note 11 to the Condensed Consolidated Financial Statements and is incorporated by reference herein."}